Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,048 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,679 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00083005 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | completed | Phase 2 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 |
| clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT01340599 | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | terminated | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT01048151 | TNFerade Biologic to Treat Locally Advanced Prostate Cancer | unknown | Phase 1 | 20 | GenVecINDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00247169 | Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II | completed | Phase 2 | 40 | Medical University of ViennaOTHER | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00601601 | Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix | completed | — | 80 | British Columbia Cancer AgencyOTHER | 0 | Mar 9, 2012 | clinicaltrials |
| NCT01549782 | Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. | completed | N/A | 40 | Hospital General Universitario Gregorio MarañonOTHER | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00773318 | SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer | terminated | N/A | 30 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | terminated | Phase 1 | 8 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01096381 | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | terminated | — | 8 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00585741 | Pilot Study of 18F-FLT PET | terminated | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Feb 23, 2012 | clinicaltrials |
| NCT01092988 | A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 40 | InSightecINDUSTRY | 4 | Feb 22, 2012 | clinicaltrials |
| NCT00403221 | Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer | completed | Phase 1 | 19 | Baylor College of MedicineOTHER | 1 | Feb 10, 2012 | clinicaltrials |
| NCT00217516 | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT00288821 | Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology | completed | — | 84 | UMC UtrechtOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT01530295 | Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer | unknown | N/A | 70 | Hanjong AhnOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT00242918 | Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | completed | Phase 2 | 29 | Benaroya Research InstituteOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00900094 | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer(IRB 2000-294) | completed | — | 200 | University of Michigan Rogel Cancer CenterOTHER | 0 | Feb 7, 2012 | clinicaltrials |
| NCT00177125 | Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP | completed | Phase 3 | 220 | University of MinnesotaOTHER | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00736164 | Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 6, 2012 | clinicaltrials |
| NCT01325844 | The Effects of Epidural Anesthesia on the Bioavailability of Nitric Oxide and Renal Function in Patients Undergoing Laparoscopic Surgery | completed | N/A | 45 | Yonsei UniversityOTHER | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00426777 | Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer | completed | Phase 3 | 160 | CMX ResearchOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01525914 | Response of Patients on Surveillance for Prostate Cancer to Dutasteride | completed | — | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00034281 | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | completed | Phase 1 | 16 | TakedaINDUSTRY | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00147680 | Uterine Papillary Serous Cancer (UPSC) Trial | completed | Phase 2 | 30 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01008969 | Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients | completed | N/A | 10 | University of California, San FranciscoOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00029224 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | completed | Phase 4 | 500 | NovartisINDUSTRY | 1 | Feb 1, 2012 | clinicaltrials |
| NCT01523652 | Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients | completed | — | 29 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00698711 | Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21 | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01132404 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | terminated | Phase 1 / Phase 2 | 9 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00243685 | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis | completed | Phase 2 / Phase 3 | 150 | Pierian BiosciencesINDUSTRY | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00283062 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 228 | SanofiINDUSTRY | 17 | Jan 26, 2012 | clinicaltrials |
| NCT00581724 | Pain in Cancer Survivors | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00607607 | A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer | completed | Phase 2 | 44 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00526331 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | completed | Phase 4 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT01078545 | Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)(LEMON) | completed | — | 729 | AbbottINDUSTRY | 2 | Jan 16, 2012 | clinicaltrials |
| NCT01510288 | Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | terminated | Phase 1 | 28 | Amsterdam UMC, location VUmcOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00020696 | Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 4 | Jan 10, 2012 | clinicaltrials |
| NCT00620243 | Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. | completed | Early Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00705835 | Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel | completed | Phase 1 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00245050 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | completed | Phase 3 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01492270 | Imaging for Significant Prostate Cancer Risk Evaluation(PICTURE) | unknown | N/A | 126 | University College London HospitalsOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00116779 | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 127 | Ferring PharmaceuticalsINDUSTRY | 2 | Dec 19, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Mar 15, 2012source: clinicaltrials